SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-025336
Filing Date
2021-11-04
Accepted
2021-11-04 17:25:19
Documents
17
Period of Report
2021-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbyi20211104_8k.htm   iXBRL 8-K 30130
2 EXHIBIT 1.1 ex_302823.htm EX-1.1 227288
3 EXHIBIT 5.1 ex_302510.htm EX-5.1 12336
8 image01.jpg GRAPHIC 3775
9 image02.jpg GRAPHIC 2449
  Complete submission text file 0001437749-21-025336.txt   469726

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20211104.xsd EX-101.SCH 3593
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20211104_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20211104_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20211104_pre.xml EX-101.PRE 11584
10 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20211104_8k_htm.xml XML 2559
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 211381244
SIC: 2834 Pharmaceutical Preparations